These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 38255879)

  • 1. Lupus Nephritis Biomarkers: A Critical Review.
    Alduraibi FK; Tsokos GC
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Novel Blood-Based Biomarkers for Lupus Nephritis Beyond Diagnostic Approaches.
    Maravillas-Montero JL; Reyes-Huerta RF
    Rev Invest Clin; 2022; 74(5):227-231. PubMed ID: 36327996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus nephritis: new progress in diagnosis and treatment.
    Yu C; Li P; Dang X; Zhang X; Mao Y; Chen X
    J Autoimmun; 2022 Oct; 132():102871. PubMed ID: 35999111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
    Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A
    Front Immunol; 2020; 11():256. PubMed ID: 32265898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis.
    Ebaid AM; Ezzeldin N; Abdelhady EI; Mohammed HA; Abdallah AL
    Lupus; 2023 Jan; 32(1):101-110. PubMed ID: 36418233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lupus nephritis: from diagnosis to treatment].
    Weinmann-Menke J
    Inn Med (Heidelb); 2023 Mar; 64(3):225-233. PubMed ID: 36763102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus nephritis.
    Anders HJ; Saxena R; Zhao MH; Parodis I; Salmon JE; Mohan C
    Nat Rev Dis Primers; 2020 Jan; 6(1):7. PubMed ID: 31974366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of interleukin-17 and interleukin-23 for estimating disease activity and predicting the response to treatment in active lupus nephritis patients.
    Dedong H; Feiyan Z; Jie S; Xiaowei L; Shaoyang W
    Immunol Lett; 2019 Jun; 210():33-39. PubMed ID: 31004679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
    Hailu GT; Hussen SU; Getachew S; Berha AB
    BMC Nephrol; 2022 Jun; 23(1):214. PubMed ID: 35715762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review.
    Radin M; Miraglia P; Barinotti A; Fenoglio R; Roccatello D; Sciascia S
    Am J Nephrol; 2021; 52(7):559-571. PubMed ID: 34515043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine biomarker score captures response to induction therapy with lupus nephritis.
    Cody EM; Wenderfer SE; Sullivan KE; Kim AHJ; Figg W; Ghumman H; Qiu T; Huang B; Devarajan P; Brunner HI
    Pediatr Nephrol; 2023 Aug; 38(8):2679-2688. PubMed ID: 36715772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of urinary kidney injury molecule 1 (KIM-1) in monitoring the treatment response in Egyptian Lupus Nephritis Patients.
    Khedr L; El-Shinnawy H; Hebah H; Rashwan H; Elsharabasy RM
    Egypt J Immunol; 2024 Jan; 31(1):124-132. PubMed ID: 38224469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lupus nephritis management renaissance.
    Mejia-Vilet JM; Malvar A; Arazi A; Rovin BH
    Kidney Int; 2022 Feb; 101(2):242-255. PubMed ID: 34619230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
    Ding H; Kharboutli M; Saxena R; Wu T
    Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of Lupus Nephritis.
    Alforaih N; Whittall-Garcia L; Touma Z
    J Appl Lab Med; 2022 Oct; 7(6):1450-1467. PubMed ID: 35932197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic identification of key extracellular proteins as the potential biomarkers in lupus nephritis.
    Zhou X; Zhang Y; Wang N
    Front Immunol; 2022; 13():915784. PubMed ID: 35967373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
    Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
    Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Kidney Biopsy in Systemic Lupus Erythematosus: A View of the Past and a Vision of the Future.
    Ayoub I; Cassol C; Almaani S; Rovin B; Parikh SV
    Adv Chronic Kidney Dis; 2019 Sep; 26(5):360-368. PubMed ID: 31733720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.